Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients
Description
Medication-enhanced psychotherapies are increasingly used to treat Post Traumatic Stress Disorder (PTSD). Esketamine, used in patients with treatment-resistant depression (TRD), sounds very promising as a new treatment for PTSD. Thus, our main objective was to investigate whether Esketamine associated with psychotherapy could reduce symptoms of both depression and PTSD in patients with complex PTSD.
Format
Journal
Language
English
Original Work Citation
Roullet, P., Pons, L., Delmas, P., Weber, C., & Raynaud de Prigny, P. (2025, March). Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients. European Journal of Trauma & Dissociation, 9(1), 100490. doi:10.1016/j.ejtd.2024.100490
Collection
Citation
“Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients,” Francine Shapiro Legacy Library, accessed November 13, 2025, https://francineshapirolibrary.omeka.net/items/show/29454.
